BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 11009747)

  • 21. The dilemmas of incrementalism: logical and political constraints in the design of health insurance reforms.
    Oliver TR
    J Policy Anal Manage; 1999; 18(4):652-83. PubMed ID: 10915452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The legal framework for effective competition.
    Berenson RA; Hastings DA; Kopit WG
    Baxter Health Policy Rev; 1996; 2():235-65. PubMed ID: 11066262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Choosing among health plans.
    Enthoven AC; Singer SJ
    Health Care Manag; 1994 Aug; 1(1):45-56. PubMed ID: 10152356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monopoly, monopsony, and market definition: an antitrust perspective on market concentration among health insurers.
    Hyman DA; Kovacic WE
    Health Aff (Millwood); 2004; 23(6):25-8. PubMed ID: 15537581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small group reform and insurance provision by small firms, 1989-1995.
    Jensen GA; Morrisey MA
    Inquiry; 1999; 36(2):176-87. PubMed ID: 10459372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk selection in the health care market: a workshop overview.
    Gauthier AK; Lamphere JA; Barrand NL
    Inquiry; 1995; 32(1):14-22. PubMed ID: 7713613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Competition in health insurance markets: limitations of current measures for policy analysis.
    Scanlon DP; Chernew M; Swaminathan S; Lee W
    Med Care Res Rev; 2006 Dec; 63(6 Suppl):37S-55S. PubMed ID: 17099129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dominos that wouldn't fall: understanding the failure of competitive reform.
    Higgins W
    J Am Health Policy; 1991; 1(3):29-35. PubMed ID: 10116468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Fortune 500 on health care. Most top executives want to set the market free.
    West VL; Minifie JR; Aiyer JP
    Mark Health Serv; 1997; 17(3):5-10. PubMed ID: 10173910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Market competition in health care markets in the Netherlands: some lessons for England?
    den Exter AP; Guy MJ
    Med Law Rev; 2014; 22(2):255-73. PubMed ID: 24841530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal risk adjustment with adverse selection and spatial competition.
    Jack W
    J Health Econ; 2006 Sep; 25(5):908-26. PubMed ID: 16712986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Markets for hospital services in Zambia.
    Nakamba P; Hanson K; McPake B
    Int J Health Plann Manage; 2002; 17(3):229-47. PubMed ID: 12298145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insurer competition and protection from risk redefinition in the individual and small group health insurance market.
    Dowd B; Feldman R
    Inquiry; 1992; 29(2):148-57. PubMed ID: 1612716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Managed care patient protection or provider protection? A qualitative assessment.
    Hall MA
    Am J Med; 2004 Dec; 117(12):932-7. PubMed ID: 15629732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is there a business case for quality in The Netherlands? A critical analysis of the recent reforms of the health care system.
    Custers T; Arah OA; Klazinga NS
    Health Policy; 2007 Jul; 82(2):226-39. PubMed ID: 17070956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is there evidence that recent consolidation in the health insurance industry has adversely affected premiums?
    Kopit WG
    Health Aff (Millwood); 2004; 23(6):29-31. PubMed ID: 15537582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Market forces inevitable in health care].
    Maljers J
    Ned Tijdschr Geneeskd; 2006 May; 150(18):1014. PubMed ID: 16715864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Why some market reforms lack legitimacy in health care.
    Laugesen M
    J Health Polit Policy Law; 2005 Dec; 30(6):1065-100. PubMed ID: 16481308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pricing behaviour of nonprofit insurers in a weakly competitive social health insurance market.
    Douven RC; Schut FT
    J Health Econ; 2011 Mar; 30(2):439-49. PubMed ID: 21295365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consumer choice among Mutual Healthcare Purchasers: a feasible option for China?
    Xu W; van de Ven WP
    Soc Sci Med; 2013 Nov; 96():277-84. PubMed ID: 23261255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.